Dana Aftab, CSO/EVP Disc & Trans Research at EXELIXIS, INC. (EXEL), sold 96,986 shares at $35.00 ($3.4M) on 2024-11-05, disclosed to the SEC on 2024-11-07.
Scheduled sale ($3.4M) by CSO/EVP Disc & Trans Research under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| Filing → |
| EXEL | SELL | 2026-02-23 | $1.3M | — | Filing → |
| EXEL | SELL | 2025-11-13 | $4.1M | — | Filing → |
| EXEL | SELL | 2025-05-05 | $59K | — | Filing → |